We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled-analysis.
- Authors
Li, Yuping; Zhang, Jun; Wang, Haili; Zhu, Lei; Zhang, Hengzhu; Ma, Qiang; Liu, Xiaoguang; Dong, Lun; Lu, Guangyu
- Abstract
Objective: The aim of this meta-analysis was to review the scientific literature published until April 18, 2021, to summarize existing knowledge on the efficacy and safety of erythropoietin (EPO) for traumatic brain injury (TBI). Methods: This systematic review followed PRISMA guidelines. Randomized controlled trials (RCTs) reporting on the efficacy and safety of EPO in the treatment of TBI were systematically searched in relevant electronic databases according to a pre-designed search strategy. The primary outcomes are the mortality; and secondary outcomes are the good functional outcome (GFO) and adverse events (AEs). Results: A total of 10 RCTs involving 2,402 participants fulfilled the inclusion criteria. The results showed that there is a significant difference in terms of the mortality (RR = 0.67, 95% CI = 0.54–0.84, P = 0.0003) and seizure rate (RR = 0.52, 95% CI = 0.29–0.96, P = 0.04) between the EPO groups compared to those in the control groups. However, compared with the control groups, the GFO in the EPO groups was not statistically significant (RR = 1.18, 95% CI = 0.93–1.48, P = 0.17). Conclusions: Findings of the present meta-analysis suggest that the use of EPO could reduce mortality rate in patients with TBI, without increasing the incidence of AEs. EPO has potential research and application value in the treatment of TBI.
- Subjects
BRAIN injuries; ERYTHROPOIETIN; SCIENCE publishing; RANDOMIZED controlled trials; TOTAL body irradiation
- Publication
Neurological Sciences, 2022, Vol 43, Issue 6, p3783
- ISSN
1590-1874
- Publication type
Article
- DOI
10.1007/s10072-022-05877-4